Kidney Transplant Conversations - Health Equity Edition

S1.E5. Fostering workforce diversity and preventing burnout. Featuring transplant recipient and innovation leader, Dr. Robert Montgomery.

Kidney transplant surgeon Dr. Robert Montgomery discusses his own experience of receiving a heart transplant three years ago. This led him to a new understanding of the challenging “new normal” for patients after a transplant, which involves multiple medications and many new responsibilities. We also discuss the evolving impacts of the ongoing COVID-19 pandemic on an estimated 10 million people with compromised immune systems.
Dr. Montgomery talks about his health equity leadership role at NYC Langone, where intentional policies are helping to foster diverse hiring and retention of health workers from underrepresented groups. He also shares some of the ways that the institute is improving health outcomes in transplantation, through research into disparities and understanding of their root causes, particularly social determinants. With podcast host Rolf Taylor.
All views and opinions expressed in this podcast reflect those of the participants.
We thank the participants and advisors who help make Kidney Transplant Conversations possible.
Kidney Transplant Conversations is underwritten by Veloxis Pharmaceuticals, Inc. All views and opinions expressed in the podcast reflect those of the participants and do not necessarily represent the views and opinions of Veloxis Pharmaceuticals, Inc.
© Project Advocacy, 2022-2023
 

S1 E4. Kidney transplant equity discussions are translating into action. But can the transplant workup widen disparities? With Dr. Velma Scantlebury.

In this episode of Kidney Transplant Conversations, we are joined by history maker Dr. Velma Scantlebury, who became the first Black female transplant surgeon in the US in 1989. 
In a wide-ranging discussion we ask whether all the current talk about health equity is resulting in real action, and we explore several current examples of intentional change. Firstly, the “Boldly Against Racism” Campaign at the American Society of Transplant Surgeons (ASTS); secondly, the updated Hippocratic Oath at Columbia University Vagelos College of Physicians and Surgeons, clearly centering health equity, diversity, and inclusion; and thirdly the recent recommendations affecting the way that kidney function calculations (eGFR) are made. Dr. Scantlebury also shares her concerns that patients with fewer resources are being disadvantaged by the burden of appointments required in preparing for a transplant and this may extend how long patients are kept on dialysis, acting as a potential barrier to transplantation. 
We also discuss ways that consideration of social determinants, along with a more diverse healthcare team, can help improve the quality of care for kidney disease patients, and help to increase the number of kidney transplants received. With podcast host Rolf Taylor. 
All views and opinions expressed in this podcast reflect those of the participants.
We thank the participants and advisors who help make Kidney Transplant Conversations possible.
Kidney Transplant Conversations is underwritten by Veloxis Pharmaceuticals, Inc. All views and opinions expressed in the podcast reflect those of the participants and do not necessarily represent the views and opinions of Veloxis Pharmaceuticals, Inc.
© Project Advocacy, 2022-2023

S1.E3. Can satellite clinics reduce rural health disparities in kidney transplantation? With Silas Norman, MD, MPH.

With Dr. Silas Norman, University of Michigan
In this podcast we discuss two potential challenges in managing chronic kidney disease and kidney transplants: the first is care when you live a long distance from specialist care, and the second is potential financial barriers. Our guest in this episode, Dr. Silas Prescod Norman, tells us about some very real ways that his hospital center has worked proactively to address both barriers, and with tangible results. Silas Prescod Norman, M.D., M.P.H is a nephrologist at the University of Michigan, working in the transplant program since 2002, and he currently serves as the co-Medical Director for kidney and pancreas transplant and Medical Director of the Transplant Multidisciplinary Ambulatory Clinics, which see more than 18,000 patient visits annually. Dr. Norman has made numerous contributions to the transplant program including the development of outreach satellite clinics to allow patients greater access to transplant opportunities, the focus of today’s episode.   Dr. Norman also serves with and volunteers for a number of organizations related to kidney transplantation, including the National Kidney Foundation of Michigan, The American Kidney Fund, and MOTTEP, the Minority Organ Tissue Transplant Education Program and more recently became an advisor to this podcast, representing the American Society of Transplantation. All views and opinions expressed in this podcast reflect those of the participants.
We thank the participants and advisors who help make Kidney Transplant Conversations possible.
Kidney Transplant Conversations is underwritten by Veloxis Pharmaceuticals, Inc. All views and opinions expressed in the podcast reflect those of the participants and do not necessarily represent the views and opinions of Veloxis Pharmaceuticals, Inc.
© Project Advocacy, 2022-2023

S1.E2. Kidney transplant disparities among Asian, Pacific Islander, Hispanic populations, and in Japan. With Dr. Joyce Trompeta.

International perspectives on organ donation and transplantation with Dr. Joyce Trompeta.
In this episode we meet Dr. Joyce Trompeta, A Nurse Practitioner (NP) specializing in transplantation, and an Associate Professor in the school of medicine, at the University of California, San Francisco where she conducts outcome research in the department of surgery. Dr. Trompeta discusses several areas of interest, including her concerns about disparities impacting Asian American, Pacific Islander and Latino populations; her work in Hawaii; how young Latinos with kidney disease are facing unique challenges relating to immigration; and her travels to Japan, where stigma and cultural beliefs have limited organ transplantation, but where the younger generations are now leading change with a little help from Kumamon, Japan’s most popular Bear.
All views and opinions expressed in this podcast reflect those of the participants.
We thank the participants and advisors who help make Kidney Transplant Conversations possible.
Kidney Transplant Conversations is underwritten by Veloxis Pharmaceuticals, Inc. All views and opinions expressed in the podcast reflect those of the participants and do not necessarily represent the views and opinions of Veloxis Pharmaceuticals, Inc.
© Project Advocacy, 2021-2023
 
 

S1.E1. Culturally sensitive kidney care: How the UNC Chapel Hill Latino Transplant Clinic is increasing access for Hispanics. With Pablo Serrano, MD, and Daniela Matz.

Featuring Transplant Social Worker Daniela Matz and clinic founder Dr. Pablo Serrano at the University of North Carolina Transplant Latino Transplant Clinic.
The clinic is the culmination of a very intentional vision, a strategic decision to integrate a Latino-focused Transplant Clinic within the Abdominal Transplant Division at UNC Chapel Hill. Since being established in 2018, they have gone on to demonstrate how workforce diversity and cultural competency go hand in hand in the delivery of quality care.
In today’s episode, transplant social worker Daniela Matz and clinic founder Dr. Pablo Serrano look back on Jose and Xiomara’s Flores story, and share with us insights into how the clinic works, and how they have been able to reduce renal transplant disparities in North Carolina. 
 
All views and opinions expressed in this podcast reflect those of the participants.
We thank the participants and advisors who help make Kidney Transplant Conversations possible.
Kidney Transplant Conversations is underwritten by Veloxis Pharmaceuticals, Inc. All views and opinions expressed in the podcast reflect those of the participants and do not necessarily represent the views and opinions of Veloxis Pharmaceuticals, Inc.
© Project Advocacy, 2021-2023